日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rapidly Progressive Pulmonary Hypertension: Importance of Vascular Disease Distribution

快速进展性肺动脉高压:血管疾病分布的重要性

Tada, Atsushi; Fayyaz, Ahmed U; Reddy, Yogesh N V; Redfield, Margaret M; Borlaug, Barry A

Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension

第一组肺动脉高压患者的肺动脉楔压升高

Reddy, Yogesh N V; Frantz, Robert P; Miranda, William R; Asokan, Aneesh K; Varma, Revati; Rischard, Franz; Hassoun, Paul M; Hemnes, Anna R; Horn, Evelyn; Leopold, Jane A; Rosenzweig, Erika B; Hill, Nicholas S; Erzurum, Serpil C; Beck, Gerald J; Barnard, John; Finet, J Emanuel; Kwon, Deborah; Mathai, Stephen C; Mukherjee, Monica; Tang, W H Wilson; Nair, K Sreekumaran; Borlaug, Barry A

Implications of Potential Undiagnosed HFpEF on Symptomatic Response With Coronary Revascularization

未确诊的HFpEF对冠状动脉血运重建术后症状缓解的影响

Bergeron, Nicholas P; Egbe, Alexander C; Miranda, William R; Gulati, Rajiv; Demmer, Ryan T; Sundaram, Varun; Borlaug, Barry A; Reddy, Yogesh N V

Progression From Exercise-Induced to Resting Left Atrial Hypertension in HFpEF: Impact of Reduced Atriopulmonary Compliance

HFpEF患者运动诱发性左心房高压向静息性左心房高压的进展:心房肺顺应性降低的影响

Tada, Atsushi; Naser, Jwan A; Doi, Shunichi; Harada, Tomonari; Ibe, Tatsuro; Kazui, Sho; Reddy, Yogesh N V; Redfield, Margaret M; Borlaug, Barry A

Prevalence and Associations of Systemic Inflammation in Heart Failure Across the Spectrum of Ejection Fraction

射血分数谱系中心力衰竭患者全身炎症的患病率及相关性

Borlaug, Barry A; Holse, Cecilie; Jung, Mette Holme; Lincoff, A Michael; Mulvagh, Sharon L; Stærk-Østergaard, Jacob; Tuttle, Katherine R; Petrie, Mark C

What Exactly Is Cardiometabolic HFpEF: A Phenotype or an Endotype?

究竟什么是心血管代谢性HFpEF:一种表型还是一种内型?

Packer, Milton; Schiattarella, Gabriele G; Borlaug, Barry A

Burden of Potentially Undiagnosed Heart Failure With Preserved Ejection Fraction in Atrial Fibrillation and Effects of Catheter Ablation: Insights From CABANA

房颤患者中潜在未确诊的射血分数保留型心力衰竭的负担及导管消融术的影响:来自 CABANA 研究的启示

Reddy, Yogesh N V; Bergeron, Nicholas; Carter, Rickey E; Redfield, Margaret M; Borlaug, Barry A

Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial

替泽帕肽对射血分数保留型心力衰竭合并肥胖患者的循环超负荷和终末器官损伤的影响:SUMMIT试验的二次分析

Borlaug, Barry A; Zile, Michael R; Kramer, Christopher M; Baum, Seth J; Hurt, Karla; Litwin, Sheldon E; Murakami, Masahiro; Ou, Yang; Upadhyay, Navneet; Packer, Milton

Pathophysiological insights into HFpEF from studies of human cardiac tissue

通过对人类心脏组织的研究,深入了解HFpEF的病理生理机制

Fayyaz, Ahmed U; Eltony, Muhammad; Prokop, Larry J; Koepp, Katlyn E; Borlaug, Barry A; Dasari, Surendra; Bois, Melanie C; Margulies, Kenneth B; Maleszewski, Joesph J; Wang, Ying; Redfield, Margaret M

Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting

在门诊环境下,基于循证医学的利钠肽在评估射血分数保留型慢性心力衰竭中的应用

Reddy, Yogesh N V; Tada, Atsushi; Obokata, Masaru; Carter, Rickey E; Kaye, David M; Handoko, M Louis; Andersen, Mads J; Sharma, Kavita; Tedford, Ryan J; Redfield, Margaret M; Borlaug, Barry A